Follow us on twitter: @csjmagazine
NEWS
UK cancer patients more likely to die following COVID-19 than European patients
Cancer patients from the UK were 1.5 times more likely to die following a diagnosis with COVID-19 than cancer patients from European countries. This is the finding of a study of over 1,000 patients – 924 from European countries and 468 from the UK – during the first wave of the COVID-19 pandemic. The research team, led by Imperial College London, said the study highlights the need for UK cancer patients to be prioritised for vaccination.
The study tracked data between 27
February to 10 September 2020, across 27 centres in six countries: Italy, Spain, France, Belgium, Germany and the UK. The results, published in the European Journal of Cancer, showed that 30 days after a COVID-19 diagnosis, 40.38% of UK cancer patients had died, versus 26.5% of European patients. Six months after a COVID-19 diagnosis, 47.64% of UK cancer patients had died, compared to 33.33% of European patients. Dr. David Pinato, lead author of the study from Imperial’s Department of Surgery and Cancer, commented: “This is the first study showing UK cancer patients were more likely to die following a COVID-19 diagnosis compared to European patients. We knew the UK had one of the highest deaths rates from COVID-19. “However, in addition to this, prior to COVID-19, the UK already lagged behind European nations in terms of cancer care, with the UK having lower survival rates from many cancers compared to many other EU nations. “We need to now prioritise cancer patients in the UK, as this study suggests they are extremely vulnerable – more so than in many other countries.”
The study also found that UK patients were less likely to be receiving cancer
treatment at the time of COVID-19 diagnosis, compared to European patients. This was most likely due to guidance from the UK National Institute for Health and Care Excellence, said the team, which recommended pausing cancer treatment during the first UK wave of COVID-19, due to concerns cancer treatment would increase risk of COVID-19. However, the study found pausing cancer treatment did not affect risk of death following COVID-19 diagnosis. The study also found equal proportions between the UK and EU of complicated COVID-19 cases, rates of intensive care admission and use of ventilation.
In addition to this, UK cancer patients were less likely to receive anti-COVID-19 therapies including corticosteroids, anti-virals and interleukin-6 antagonists. There were
also similar rates of admission to intensive care units.
The study team added that UK cancer patients tended to be more frail than European cancer patients, which may have led to the increased death rates following a COVID-19 diagnosis. Dr. Alessio Cortellini, co-author of the paper from the Department of Surgery and Cancer, commented:
“UK cancer patients tended to be older than European patients, were more likely to be male, and have other conditions such as obesity or diabetes. All of these may have contributed to the increased mortality rate, and show why cancer patients should be prioritised for COVID-19 vaccination.” The study was supported by the National Institute for Health Research Imperial Biomedical Research Centre.
Incomparable Cleaning Performance (UK) Ltd
Upgrade your reusable and disposable surgical instrument cleaning brushes
- Ergonomic design - Reduce cleaning time - More effective cleaning - Full range for all your cleaning needs
Contact now for more information
info@uniplexuk.com |
www.uniplexuk.com | 0114 241 3410 MAY 2021
WWW.CLINICALSERVICESJOURNAL.COM l 9
©Pormezz -
stock.adobe.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80
